A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers
NCT ID: NCT02175199
Last Updated: 2015-10-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
151 participants
INTERVENTIONAL
2014-06-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers
NCT01782482
A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDS
NCT01635933
DW Evaluation of Lotrafilcon B Lenses in a Modified Design
NCT02157909
A Comparison of Silicone Hydrogel Contact Lenses: AIR OPTIX® COLORS Versus AIR OPTIX® AQUA
NCT01635920
Multifocal Lens Design Evaluation
NCT01997216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AIR OPTIX COLORS
Lotrafilcon B contact lenses with color printing worn bilaterally in a daily wear modality 5 days/week, 8 hours/day for 30 days.
Lotrafilcon B contact lenses with color printing
FreshLook COLORBLENDS
Phemfilcon A contact lenses with color printing worn bilaterally in a daily wear modality 5 days/week, 8 hours/day for 30 days with a 2-week replacement.
Phemfilcon A contact lenses with color printing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon B contact lenses with color printing
Phemfilcon A contact lenses with color printing
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Vision correctable to 20/30 Snellen (feet) or better in each eye at distance with pre-study contact lenses.
* Manifest cylinder (at screening) less than or equal to 0.75 diopters (D) in each eye.
* Successful wear of clear/handling tint, single-vision spherical, bi-weekly/ monthly replacement soft contact lenses in both eyes during the past 2 months for a minimum of 5 days per week and 8 hours per day.
* Requires spherical contact lenses within the available range of powers (i.e.,-1.50D to -5.00D in 0.25D steps).
* Interested in wearing contact lenses that change the appearance of the color of the eyes.
Exclusion Criteria
* History of herpetic keratitis.
* Any use of systemic or ocular medications for which contact lens wear could be contraindicated including any use of topical ocular medications that would require instillation during contact lens wear, except for rewetting drops.
* Corneal vascularization greater than 1 millimeter (mm) of penetration.
* Habitual lenses worn in an extended wear modality (routinely sleeping in lenses overnight for 1 night per week or more) over the last 3 months prior to enrollment.
* Previous corneal or refractive surgery or irregular cornea.
* Monovision and monocular (only 1 eye with functional vision) or fit with only 1 lens.
* Anisometropia ≥1.50D (study contact lens prescription).
* History of intolerance or hypersensitivity to any component of the test articles.
* Eye injury or ocular or intra-ocular surgery within the last 6 months (excluding placement of punctal plugs).
* Participation in any clinical study within 30 days of Visit 1.
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Global Brand Lead, GCRA, Vision Care
Role: STUDY_DIRECTOR
Alcon Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-14-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.